Allergy Diagnostics Market by Product (Assay Kits, Immunoassay and Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory, Research) - Global Forecast to 2024

  • Report ID:MRHC - 104262
  • Pages: 120
  • Apr 2019
  • Formats*: PDF
  • Category: Healthcare

1 Introduction
   1.1 Objectives of the Study
   1.2 Market Definition
   1.3 Market Scope
         1.3.1 Markets Covered
         1.3.2 Years Considered for the Study
   1.4 Currency
   1.5 Limitations
   1.6 Stakeholders

2 Research Methodology
   2.1 Secondary Research
   2.2 Primary Research
   2.3 Market Estimation

3 Executive Summary

4 Market Insights
   4.1 Introduction
   4.2 Drivers
         4.2.1 Rising Environmental Pollution Levels
         4.2.2 High Incidence and Large Economic Burden of Allergic Diseases
         4.2.3 Technological Advancements
         4.2.4 Improving Coverage for Allergy Diagnosis
   4.3 Restraints
         4.3.1 Lack of awareness of Allergic Diseases
         4.3.2 Issues Related to the Affordability of Allergy Diagnostics Instruments Among Small
                  Laboratories and Physician Clinics
   4.4 Opportunities
         4.4.1 Emerging Markets

5 Global Allergy Diagnostics Market, by Product & Service
   5.1 Introduction
   5.2 Assay Kits
   5.3 Instruments
         5.3.1 Immunoassay Analyzers
         5.3.2 Luminometers
         5.3.3 ELISA Analyzers
         5.3.4 Other Instruments
   5.4 Services

6 Global Allergy Diagnostics Market, By Test
   6.1 Introduction
   6.2 In Vitro Tests
   6.3 In Vivo Tests

7 Global Allergy Diagnostics Market, By Allergen
   7.1 Introduction
   7.2 Inhaled Allergens
   7.3 Food Allergens
   7.4 Drug Allergens
   7.5 Other Allergens

10 Global Allergy Diagnostics Market, By End User
     10.1 Introduction
     10.2 Diagnostic Laboratories
     10.3 Hospital-Based Laboratories
     10.4 Academic Research Institutes
     10.5 Other End Users

11 Global Allergy Diagnostics Market, By Region
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 U.K.
             11.3.3 France
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 RoE
     11.4 Asia-Pacific
             11.4.1 China
             11.4.2 Japan
             11.4.3 India
             11.4.4 RoAPAC
     11.5 Rest of the World
             11.5.1 Latin America
             11.5.2 Middle East & Africa

12 Competitive Landscape
     12.1 Introduction
     12.2 Company Benchmarking
     12.3 Market Share Analysis

13 Company Profiles
     13.1 Biomérieux SA
             13.1.1 Business Overview
             13.1.2 Financial Portfolio
             13.1.3 Product Portfolio
             13.1.4 Strategic Developments
     13.2 Hitachi Chemical Co., Ltd.
             13.2.1 Business Overview
             13.2.2 Financial Portfolio
             13.2.3 Product Portfolio
             13.2.4 Strategic Developments
     13.3 Hob Biotech Group Suzhou Co., Ltd.
             13.3.1 Business Overview
             13.3.2 Financial Portfolio
             13.3.3 Product Portfolio
             13.3.4 Strategic Developments
     13.4 Hycor Biomedical, Inc.
             13.4.1 Business Overview
             13.4.2 Financial Portfolio
             13.4.3 Product Portfolio
             13.4.4 Strategic Developments
     13.5 Lincoln Diagnostics, Inc.
             13.5.1 Business Overview
             13.5.2 Financial Portfolio
             13.5.3 Product Portfolio
             13.5.4 Strategic Developments
     13.6 Omega Diagnostics Group PLC
             13.6.1 Business Overview
             13.6.2 Financial Portfolio
             13.6.3 Product Portfolio
             13.6.4 Strategic Developments
     13.7 R-Biopharm AG
             13.7.1 Business Overview
             13.7.2 Financial Portfolio
             13.7.3 Product Portfolio
             13.7.4 Strategic Developments
     13.8 Stallergenes Greer
             13.8.1 Business Overview
             13.8.2 Financial Portfolio
             13.8.3 Product Portfolio
             13.8.4 Strategic Developments
     13.9 Siemens AG
             13.9.1 Business Overview
             13.9.2 Financial Portfolio
             13.9.3 Product Portfolio
             13.9.4 Strategic Developments
     13.10 Thermo Fisher Scientific Inc.
             13.10.1 Business Overview
             13.10.2 Financial Portfolio
             13.10.3 Product Portfolio
             13.10.4 Strategic Developments

14 Appendix


Meticulous Research® in its latest publication on Allergy Diagnostics Market states that the global allergy diagnostics market will increase at a CAGR of around 11.1% from 2019 to 2025 to reach $7.08 billion by 2025. Allergic diseases are affecting the lives of more than one billion people worldwide. More than 50 million Americans have experienced various types of allergies each year (Source: CDC). According to American College of Allergy, Asthma, and Immunology (ACAAI), allergies are the 6th leading cause of chronic illness in the U.S and annual cost of allergies exceeds $18 billion.

Analysis of Market Segments

The allergy diagnostics market is segmented by product & service (Assay Kits, Instruments, Services), by test (In Vivo Tests, and In Vitro Tests), by allergen (inhaled allergens, food allergens, drug allergens, and others), by end-user (diagnostic laboratories, hospital-based laboratories, academic research institutes and others), and by region.

On the basis of product & service, the allergy diagnostics market is segmented into Assay Kits, Instruments, and Services. Assay kits accounted for the largest share of this market in 2018. The large share of this segment is mainly attributed to widespread availability, lower cost, and significant consumption of assay kits in allergy testing.

Based on allergen type, the global allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2018, inhaled allergens accounted for the largest share of the global allergy diagnostics market. The large share of this segment is mainly due to increasing environmental pollution across the globe.

Based on end user, the allergy diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories, academic research institutes, and others. Diagnostic laboratories dominated the global allergy diagnostics market in 2018. The large share and high growth of this segment is attributed to increasing number of diagnostic centers, improving diagnostic lab infrastructure in developing countries, and greater preference to conduct these tests at these centers.

This research report analyzes major geographies and provides comprehensive value and volume analysis of North America (U.S., Canada), Europe (Germany, U.K., Spain, France, Italy, and RoE), Asia-Pacific (China, India, Japan, and RoAPAC), Latin America, and Middle East & Africa. North America accounted for largest share of the global allergy diagnostics market. However, APAC is expected to register highest growth during the forecast period. The high growth of this region is mainly attributed to rise in number of hospitals and diagnostic laboratories, large patient pool, increasing awareness of allergy diseases, and growing healthcare expenditure.

Key Players

The report includes competitive landscape based on extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years (2015-2018). Biomérieux SA (France), Hitachi Chemical Co., Ltd. (Japan), Hob Biotech Group Suzhou Co., Ltd. (China), Hycor Biomedical, Inc. (U.S.), Lincoln Diagnostics, Inc. (U.S.), Omega Diagnostics Group PLC (U.K.), R-Biopharm AG (Germany), Stallergenes Greer (U.K.), Siemens AG (Germany), and Thermo Fisher Scientific Inc. (U.S.) are the key players operating in this market. The players are adopting various organic and inorganic growth strategies in order to strengthen their presence and customer base.

Market Segmentation

Global Allergy Diagnostics Market, By Product & Service

  • Assay Kits
  • Instruments
  • Immunoassay Analyzers
  • Luminometers
  • Elisa Analyzers
  • Other Instruments
  • Services

Allergy Diagnostics Market, By Test

  • In Vivo Tests
  • In Vitro Tests

Allergy Diagnostics Market, By Allergen

  • Inhaled Allergens
  • Food Allergens
  • Drug Allergens
  • Other

Allergy Diagnostics Market, By End User

  • Diagnostic Laboratories
  • Hospital-based Laboratories
  • Academic Research Institutes
  • Other

Allergy Diagnostics Market, By Region/Country

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • RoE
  • Asia-Pacific
    • Japan
    • China
    • India
    • RoAPAC
  • RoW
    • Latin America
    • Middle East & Africa

Key questions answered in the report:

Growing penetration of allergy diagnostic tests in developing countries will propel the overall allergy diagnostics market

  • How does the adoption of allergy diagnostic tests in developed regions differ from developing countries like India and China?
  • How is the competition between the major global and prominent local players in developing region?
  • Which are the high growth market segments in terms of product & service, test, allergen, end users, and countries?

Diagnostic laboratories accounted for the largest share of the allergy diagnostics market globally

  • What factors contribute to the frequent usage of allergy diagnostics tests in diagnostic laboratories?
  • Which geographic region is expected to experience the fastest growth in the usage of allergy diagnostics in diagnostic laboratories, hospital-based laboratories, academic research institutes, and other end users?
  • How does the penetration of allergy diagnostics in diagnostic laboratories differ from other end users such as hospital-based laboratories, academic research institutes, and other end users?

Allergy diagnostics market favours both larger and local manufacturers that compete in multiple segments

  • What are the top competitors in this market and what strategies do they employ to gain shares?
  • What is driving growth and which market segments have the most potential for revenue expansion over the forecast period?
  • What strategies should new companies looking to enter in this market use to compete effectively?
  • What are the major drivers, restraints, and opportunities in the allergy diagnostics market?
  • Who are the major players in various countries and what share of the market do they hold?
  • What are the geographical trends and high growth regions/ countries?

Recent partnerships, acquisitions, and expansions have taken place in the global allergy diagnostics market

  • What companies have recently merged/acquired and how will these unions affect the competitive landscape of the allergy diagnostics market?
  • What companies have created partnerships and how will these partnerships promote a competitive advantage?
  • Who are the major players in the global allergy diagnostics market and what share of the market do they hold?
  • What are the local emerging players in the global allergy diagnostics market and how do they compete with the global players?
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare In Vitro Diagnostics Assays Reagents Automated Instrumentation Immunoassays Analytical Instrumentat Allergy Diagnostics Market Medical Technologies
Download Free Sample